Stay updated with breaking news from Oerth Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PROTACs use the natural garbage disposal machinery within cells to tag and remove problematic proteins, with potential applications ranging from cancer to pesticides.
Experienced biotech Chief Financial Officer Dr. Rob Quinn appointed as Oxford-based Moa develops its strong pipeline of next-generation herbicides and continues to growUnited States-based Apostolos...
The field of protein degraders is at an inflection point as more degraders enter the clinical space. Evaluating the patent filing activity will play a critical role in the ability to managing opportunities for licensing and partnerships.
Targeted protein degraders such as proteolysis targeting chimeras (PROTACs) have been a significant development in the therapeutics space. These…
– Enrollment continues globally in multiple clinical studies of vepdegestrant , including VERITAC-2 2L Phase 3 trial and study lead-in for the VERITAC-3 1L Phase 3 trial, both in ER+/HER2-...